Md. AG Files Suit Against GlaxoSmithKline
Published: Feb 22, 2013
Maryland Attorney General Douglas Gansler filed a lawsuit Wednesday against GlaxoSmithKline alleging that the pharmaceutical company used misleading marketing for the prescription drugs Avandaryl, Avandamet and Avandia. GlaxoSmithKline allegedly promoted the drugs as superior to other diabetes medications even though they were not actually better at treating the disease and withheld data that showed the drugs significantly increased a patient’s chances of suffering a heart attack or other serious complications. GlaxoSmithKline allegedly promoted the drugs as safe for use despite its knowledge of the risks. “GlaxoSmithKline has put diabetes patients at serious risk with misleading claims over the safety and efficacy of these drugs,” Gansler said.